Elzbieta Talarczyk, PhD
About Elzbieta Talarczyk, PhD
Elzbieta Talarczyk, PhD, is the Lead of Regulatory Sciences EU Local Representation Markets & Regulatory Compliance EU Countries at Bristol-Myers Squibb, with over 25 years of experience in regulatory affairs and a strong background in molecular biology.
Current Title and Role
Elzbieta Talarczyk, PhD, currently serves as the Lead for Regulatory Sciences EU Local Representation Markets & Regulatory Compliance EU Countries at Bristol-Myers Squibb. In this role, she spearheads regulatory operations and ensures compliance with regulations across multiple European countries.
Previous Positions at Bristol-Myers Squibb
Elzbieta Talarczyk joined Bristol-Myers Squibb in 2006. She has held various leadership roles including Director of Regulatory Affairs Poland (2006-2011), and Director of Regulatory Operation Liaison Europe (2011-2018) in Polska. In these positions, she played a crucial role in regulatory operations within Europe before stepping into her current role in 2018.
Experience at ICN Polfa Rzeszów and Roche
Before her tenure at Bristol-Myers Squibb, Elzbieta Talarczyk worked as the Director of Regulatory Affairs at ICN Polfa Rzeszów from 2001 to 2006 in Poland. Prior to that, she served as a Regulatory Affairs Manager at Roche from 1996 to 2001 in Poland. These roles contributed substantially to her over 25 years of experience in the pharmaceutical industry's regulatory affairs.
Educational Background in Molecular Biology
Elzbieta Talarczyk has a strong educational foundation in molecular biology. She earned her Master of Science (MS) in Molecular Biology from Uniwersytet Warszawski. She furthered her expertise by obtaining a Doctor of Philosophy (PhD) in Molecular Biology from the Institute of Biochemistry and Biophysics.
Expertise in Regulatory Compliance
Elzbieta Talarczyk has over 25 years of experience in regulatory affairs within the pharmaceutical industry. She possesses extensive expertise in regulatory compliance across multiple European countries. Her long career includes leading regulatory operations and ensuring compliance at Bristol-Myers Squibb since 2018.